Stay updated with breaking news from Full Prescribing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
STOCKHOLM, May 28, 2024 /PRNewswire/ -- Calliditas Therapeutics AB , today announced the presentations of an additional efficacy analysis of Nefecon delayed release capsules)) as well as a...
60% Complete Response Rate after JELMYTO Induction 25% of Patients Received a Ureteral Stent ...
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric and adult patients Gastroenteropancreatic neuroendocrine...
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17)...
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and...